Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/13666

TDMS Study 96018-03 Pathology Tables

NTP Experiment-Test: 96018-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                        WATER DISINFECTION BYPRODUCTS (BROMODICHLOROMETHANE)                   Date: 05/24/04
Route: DOSED WATER                                                                                                Time: 09:31:58

                                                         FINAL #2/RATS




       Facility:  Southern Research Institute

       Chemical CAS #:  75-27-4

       Lock Date:  02/19/02

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All


































a  Number of animals examined microscopically at site and number of animals with lesion

                                                              Page   1


NTP Experiment-Test: 96018-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                        WATER DISINFECTION BYPRODUCTS (BROMODICHLOROMETHANE)                   Date: 05/24/04    
Route: DOSED WATER                                                                                                Time: 09:31:58    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0 MG/L       175 MG/L     350 MG/L     700 MG/L                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                16           19           14           15                                     
    Natural Death                                      5            2            7            9                                     
    Accidently Killed                                               1                                                               
  Survivors                                                                                                                         
    Terminal Sacrifice                                28           27           29           26                                     
    Moribund Sacrifice                                 1            1                                                               
                                                                                                                                    
  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Cecum                             (46)         (49)         (44)         (43)                                   
      Edema                                                                      1 (2%)                                             
   Liver                                              (50)         (50)         (50)         (50)                                   
      Angiectasis, Focal                               4 (8%)       4 (8%)       5 (10%)      2 (4%)                                
      Basophilic Focus                                33 (66%)     25 (50%)     24 (48%)     17 (34%)                               
      Cholangiofibrosis                                1 (2%)       2 (4%)       1 (2%)       1 (2%)                                
      Clear Cell Focus                                28 (56%)     24 (48%)     19 (38%)     17 (34%)                               
      Congestion                                       2 (4%)       1 (2%)       1 (2%)       4 (8%)                                
      Degeneration, Cystic, Focal                     31 (62%)     24 (48%)     23 (46%)     29 (58%)                               
      Eosinophilic Focus                                            1 (2%)       4 (8%)                                             
      Fibrosis, Focal                                  1 (2%)       1 (2%)       1 (2%)       3 (6%)                                
      Hemorrhage, Focal                                                                       1 (2%)                                
      Hepatodiaphragmatic Nodule                       5 (10%)      5 (10%)     12 (24%)      4 (8%)                                
      Hyperplasia, Focal, Histiocytic                                            1 (2%)                                             
      Hyperplasia, Focal, Regenerative                                                        1 (2%)                                
      Infiltration Cellular, Mixed Cell               30 (60%)     31 (62%)     34 (68%)     34 (68%)                               
      Inflammation, Chronic                           23 (46%)     29 (58%)     33 (66%)     34 (68%)                               
      Mixed Cell Focus                                              3 (6%)      10 (20%)      4 (8%)                                
      Necrosis, Focal                                  2 (4%)                                 1 (2%)                                
      Tension Lipidosis                                                          1 (2%)                                             
      Bile Duct, Hyperplasia                          45 (90%)     49 (98%)     49 (98%)     50 (100%)                              
      Hepatocyte, Fatty Change                        36 (72%)     34 (68%)     36 (72%)     40 (80%)                               
      Hepatocyte, Hyperplasia, Regenerative                                                   1 (2%)                                
      Hepatocyte, Hypertrophy                                       1 (2%)                                                          
      Hepatocyte, Vacuolization Cytoplasmic           11 (22%)     10 (20%)     19 (38%)     18 (36%)                               
      Hepatocyte, Centrilobular, Necrosis              1 (2%)       1 (2%)       1 (2%)       4 (8%)                                
      Serosa, Bile Duct, Inflammation, Chronic,                                                                                     
         Focal                                                                                1 (2%)                                
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    2                                                              
                                                                                                                                   
NTP Experiment-Test: 96018-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                        WATER DISINFECTION BYPRODUCTS (BROMODICHLOROMETHANE)                   Date: 05/24/04    
Route: DOSED WATER                                                                                                Time: 09:31:58    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0 MG/L       175 MG/L     350 MG/L     700 MG/L                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
   Mesentery                                          (15)         (13)         (14)         (15)                                   
      Hemorrhage, Focal                                                                       1 (7%)                                
      Inflammation, Chronic                            1 (7%)                    1 (7%)                                             
      Fat, Necrosis, Focal                             8 (53%)      4 (31%)      9 (64%)      7 (47%)                               
   Pancreas                                           (49)         (50)         (50)         (49)                                   
      Cyst                                                                       1 (2%)                                             
      Hyperplasia, Focal, Histiocytic                                                         1 (2%)                                
      Acinus, Atrophy, Focal                          31 (63%)     20 (40%)     23 (46%)     21 (43%)                               
      Acinus, Hyperplasia, Focal                       1 (2%)                                                                       
      Duct, Cyst                                       1 (2%)                                                                       
      Duct, Cyst, Focal, Multiple                     16 (33%)     14 (28%)     17 (34%)     11 (22%)                               
   Stomach, Forestomach                               (50)         (50)         (50)         (50)                                   
      Edema                                            2 (4%)       2 (4%)       3 (6%)       4 (8%)                                
      Erosion                                                                                 1 (2%)                                
      Inflammation, Chronic, Diffuse                                             1 (2%)                                             
      Inflammation, Diffuse                                                      2 (4%)                                             
      Inflammation, Focal                              1 (2%)       2 (4%)       2 (4%)       1 (2%)                                
      Ulcer                                            1 (2%)       4 (8%)       4 (8%)       4 (8%)                                
      Epithelium, Hyperplasia                          2 (4%)       5 (10%)      4 (8%)       6 (12%)                               
   Stomach, Glandular                                 (49)         (50)         (50)         (50)                                   
      Atypia Cellular, Focal                                                     1 (2%)                                             
      Edema                                                         1 (2%)                                                          
      Erosion                                          2 (4%)       4 (8%)       1 (2%)       4 (8%)                                
      Fibrosis, Focal                                                                         1 (2%)                                
      Infarct                                                       1 (2%)                                                          
      Inflammation, Focal                                           1 (2%)                                                          
      Pigmentation, Focal                                           1 (2%)                    1 (2%)                                
      Ulcer                                            1 (2%)                                                                       
      Artery, Inflammation, Chronic                                 1 (2%)                                                          
      Epithelium, Hyperplasia                                                                 2 (4%)                                
      Epithelium, Hyperplasia, Focal                   1 (2%)                                                                       
      Glands, Ectasia, Focal                                        1 (2%)                    1 (2%)                                
      Glands, Necrosis, Focal                                       1 (2%)                                                          
   Tongue                                             (1)          (1)          (1)          (1)                                    
      Infiltration Cellular, Focal, Mixed Cell                      1 (100%)                                                        
      Epithelium, Hyperplasia, Focal                                             1 (100%)                                           
   Tooth                                                           (1)                                                              
      Epithelium Alveolus, Hyperplasia                              1 (100%)                                                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (50)         (50)         (50)                                   
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    3                                                              
                                                                                                                                   
NTP Experiment-Test: 96018-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                        WATER DISINFECTION BYPRODUCTS (BROMODICHLOROMETHANE)                   Date: 05/24/04    
Route: DOSED WATER                                                                                                Time: 09:31:58    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0 MG/L       175 MG/L     350 MG/L     700 MG/L                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
CARDIOVASCULAR SYSTEM - CONT                                                                                                        
      Cardiomyopathy                                  16 (32%)     18 (36%)     21 (42%)     14 (28%)                               
      Fibrosis, Focal                                                            1 (2%)                                             
      Infiltration Cellular, Mixed Cell                1 (2%)                                                                       
      Thrombosis                                                    2 (4%)                    2 (4%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (50)         (50)         (49)                                   
      Accessory Adrenal Cortical Nodule               14 (28%)      8 (16%)      8 (16%)     14 (29%)                               
      Angiectasis                                                                1 (2%)                                             
      Cytoplasmic Alteration, Focal                    1 (2%)       3 (6%)       3 (6%)       2 (4%)                                
      Infiltration Cellular, Mixed Cell                             1 (2%)                                                          
      Necrosis, Focal                                  2 (4%)                    1 (2%)       1 (2%)                                
      Vacuolization Cytoplasmic, Focal                 9 (18%)      5 (10%)      8 (16%)     12 (24%)                               
   Adrenal Medulla                                    (50)         (50)         (50)         (49)                                   
      Cytoplasmic Alteration, Focal                                                           1 (2%)                                
      Hemorrhage                                                                 1 (2%)                                             
      Hyperplasia                                                                             1 (2%)                                
      Hyperplasia, Focal                              11 (22%)     17 (34%)     15 (30%)     13 (27%)                               
      Necrosis, Focal                                  1 (2%)                    1 (2%)                                             
      Thrombosis                                                                              1 (2%)                                
      Bilateral, Hyperplasia, Focal                                 1 (2%)                                                          
   Islets, Pancreatic                                 (49)         (50)         (50)         (49)                                   
      Hyperplasia                                                   1 (2%)       1 (2%)       1 (2%)                                
      Hyperplasia, Focal                               2 (4%)                                                                       
   Parathyroid Gland                                  (48)         (49)         (50)         (50)                                   
      Cyst                                                                                    1 (2%)                                
      Hyperplasia, Focal                                                         1 (2%)                                             
   Pituitary Gland                                    (49)         (50)         (50)         (48)                                   
      Angiectasis                                      2 (4%)       2 (4%)                    1 (2%)                                
      Craniopharyngeal Duct, Cyst                      1 (2%)                                                                       
      Pars Distalis, Cyst                              2 (4%)       2 (4%)       2 (4%)       2 (4%)                                
      Pars Distalis, Cytoplasmic Alteration, Focal     7 (14%)      6 (12%)      1 (2%)       6 (13%)                               
      Pars Distalis, Degeneration, Cystic, Focal       1 (2%)                                 3 (6%)                                
      Pars Distalis, Hemorrhage, Focal                 3 (6%)       5 (10%)      1 (2%)       3 (6%)                                
      Pars Distalis, Hyperplasia, Focal                3 (6%)       2 (4%)       2 (4%)       7 (15%)                               
      Pars Distalis, Necrosis, Focal                   1 (2%)                                                                       
      Pars Intermedia, Cyst                                         1 (2%)                                                          
      Rathke's Cleft, Cyst                             2 (4%)       2 (4%)                                                          
      Rathke's Cleft, Hemorrhage                                                 1 (2%)                                             
   Thyroid Gland                                      (46)         (48)         (44)         (42)                                   
      Hemorrhage                                                                 1 (2%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    4                                                              
                                                                                                                                   
NTP Experiment-Test: 96018-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                        WATER DISINFECTION BYPRODUCTS (BROMODICHLOROMETHANE)                   Date: 05/24/04    
Route: DOSED WATER                                                                                                Time: 09:31:58    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0 MG/L       175 MG/L     350 MG/L     700 MG/L                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      C-Cell, Hyperplasia                             44 (96%)     46 (96%)     40 (91%)     41 (98%)                               
      Follicle, Degeneration, Cystic, Focal                         2 (4%)                                                          
      Follicular Cell, Hyperplasia                                                            2 (5%)                                
      Follicular Cell, Hyperplasia, Cystic, Focal      5 (11%)      4 (8%)       4 (9%)       3 (7%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (49)         (50)         (50)         (50)                                   
      Inflammation, Chronic                            1 (2%)                                                                       
   Preputial Gland                                    (50)         (50)         (50)         (49)                                   
      Degeneration, Cystic                             1 (2%)                    1 (2%)       2 (4%)                                
      Fibrosis                                                                                1 (2%)                                
      Hyperplasia, Cystic                              2 (4%)       1 (2%)       1 (2%)       2 (4%)                                
      Inflammation, Chronic                           32 (64%)     30 (60%)     31 (62%)     37 (76%)                               
   Prostate                                           (50)         (50)         (50)         (50)                                   
      Inflammation, Chronic                           29 (58%)     33 (66%)     35 (70%)     38 (76%)                               
      Mineralization, Focal                                                                   2 (4%)                                
      Epithelium, Hyperplasia, Focal                  25 (50%)     21 (42%)     24 (48%)     23 (46%)                               
   Seminal Vesicle                                    (50)         (50)         (50)         (50)                                   
      Dilatation                                                                 1 (2%)                                             
      Inflammation, Chronic                                                      1 (2%)                                             
   Testes                                             (50)         (50)         (50)         (50)                                   
      Atrophy                                          5 (10%)      8 (16%)      8 (16%)      8 (16%)                               
      Necrosis                                         1 (2%)                                                                       
      Artery, Thrombosis, Focal                        1 (2%)                                                                       
      Bilateral, Atrophy                               1 (2%)                    1 (2%)       1 (2%)                                
      Bilateral, Interstitial Cell, Hyperplasia,                                                                                    
         Focal                                                      1 (2%)                                                          
      Interstitial Cell, Hyperplasia                                             1 (2%)                                             
      Interstitial Cell, Hyperplasia, Focal            3 (6%)       1 (2%)       3 (6%)       3 (6%)                                
      Tunic, Inflammation, Chronic                     1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (45)         (49)         (49)                                   
      Hyperplasia                                      2 (4%)       2 (4%)       5 (10%)      2 (4%)                                
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    5                                                              
                                                                                                                                   
NTP Experiment-Test: 96018-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                        WATER DISINFECTION BYPRODUCTS (BROMODICHLOROMETHANE)                   Date: 05/24/04    
Route: DOSED WATER                                                                                                Time: 09:31:58    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0 MG/L       175 MG/L     350 MG/L     700 MG/L                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Hyperplasia, Focal, Histiocytic                               1 (2%)                    1 (2%)                                
      Hyperplasia, Histiocytic                                      1 (2%)                                                          
      Myeloid Cell, Hyperplasia                        2 (4%)                    3 (6%)       1 (2%)                                
      Myeloid Cell, Erythroid Cell, Hyperplasia        1 (2%)       5 (11%)                   5 (10%)                               
   Lymph Node                                         (25)         (28)         (26)         (26)                                   
      Bronchial, Hyperplasia, Plasma Cell                           1 (4%)                                                          
      Deep Cervical, Ectasia                                                                  1 (4%)                                
      Mediastinal, Angiectasis                         2 (8%)                                 1 (4%)                                
      Mediastinal, Ectasia                             3 (12%)      1 (4%)       3 (12%)      4 (15%)                               
      Mediastinal, Hemorrhage                                                    1 (4%)       2 (8%)                                
      Mediastinal, Hyperplasia                                      1 (4%)                                                          
      Mediastinal, Hyperplasia, Histiocytic            2 (8%)                    1 (4%)       2 (8%)                                
      Mediastinal, Hyperplasia, Lymphoid               1 (4%)       1 (4%)       1 (4%)                                             
      Mediastinal, Hyperplasia, Plasma Cell            1 (4%)       3 (11%)      6 (23%)      1 (4%)                                
      Mediastinal, Inflammation                        1 (4%)                                                                       
      Pancreatic, Angiectasis                                                                 1 (4%)                                
      Pancreatic, Ectasia                              3 (12%)      5 (18%)      3 (12%)      5 (19%)                               
      Pancreatic, Hemorrhage                           1 (4%)                    2 (8%)       1 (4%)                                
      Pancreatic, Hyperplasia, Histiocytic             3 (12%)      7 (25%)                   5 (19%)                               
      Pancreatic, Pigmentation                         1 (4%)                    1 (4%)       1 (4%)                                
   Lymph Node, Mesenteric                             (50)         (49)         (50)         (50)                                   
      Ectasia                                                       1 (2%)                                                          
      Hemorrhage                                       2 (4%)                                 1 (2%)                                
      Hyperplasia, Histiocytic                                      2 (4%)                    1 (2%)                                
   Spleen                                             (48)         (49)         (49)         (50)                                   
      Accessory Spleen                                 1 (2%)                    1 (2%)       1 (2%)                                
      Angiectasis, Focal                               1 (2%)       2 (4%)                                                          
      Congestion                                                    1 (2%)       1 (2%)                                             
      Fibrosis, Focal                                  4 (8%)       3 (6%)       1 (2%)       1 (2%)                                
      Hematopoietic Cell Proliferation                 6 (13%)      7 (14%)      5 (10%)     11 (22%)                               
      Hemorrhage                                                                              2 (4%)                                
      Hemorrhage, Chronic                              1 (2%)                                                                       
      Hyperplasia, Focal, Histiocytic                               1 (2%)                                                          
      Hyperplasia, Lymphoid                            1 (2%)                                                                       
      Infarct                                          2 (4%)       1 (2%)       1 (2%)                                             
      Necrosis, Focal                                                                         1 (2%)                                
      Pigmentation                                                               1 (2%)                                             
      Artery, Thrombosis                               1 (2%)                                                                       
      Capsule, Fibrosis, Focal                         1 (2%)                                                                       
   Thymus                                             (48)         (48)         (50)         (47)                                   
      Hemorrhage                                                                 1 (2%)                                             
      Hyperplasia, Lymphoid                                                      1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    6                                                              
                                                                                                                                   
NTP Experiment-Test: 96018-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                        WATER DISINFECTION BYPRODUCTS (BROMODICHLOROMETHANE)                   Date: 05/24/04    
Route: DOSED WATER                                                                                                Time: 09:31:58    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0 MG/L       175 MG/L     350 MG/L     700 MG/L                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (44)         (45)         (47)         (42)                                   
      Atypia Cellular, Focal                                                     1 (2%)                                             
      Dilatation                                       8 (18%)     18 (40%)     16 (34%)     12 (29%)                               
      Ectasia                                                                    1 (2%)       1 (2%)                                
      Fibrosis                                                      1 (2%)                                                          
      Fibrosis, Focal                                                                         1 (2%)                                
      Hyperplasia                                      2 (5%)       3 (7%)       2 (4%)       1 (2%)                                
   Skin                                               (50)         (50)         (50)         (50)                                   
      Cyst Epithelial Inclusion                                                               2 (4%)                                
      Hyperkeratosis, Focal                                                                   1 (2%)                                
      Inflammation, Chronic, Focal                                               1 (2%)                                             
      Mineralization, Focal                                                      1 (2%)                                             
      Subcutaneous Tissue, Angiectasis, Focal          1 (2%)       1 (2%)                                                          
      Subcutaneous Tissue, Cyst, Chronic               1 (2%)                                                                       
      Subcutaneous Tissue, Cyst Epithelial                                                                                          
        Inclusion                                                                1 (2%)                                             
      Subcutaneous Tissue, Edema                       1 (2%)                                                                       
      Subcutaneous Tissue, Hemorrhage, Focal           1 (2%)                    1 (2%)       1 (2%)                                
      Subcutaneous Tissue, Inflammation, Focal,                                                                                     
         Granulomatous                                                           1 (2%)                                             
      Subcutaneous Tissue, Metaplasia, Focal,                                                                                       
        Osseous                                        1 (2%)                                                                       
      Subcutaneous Tissue, Necrosis, Fatty, Focal                                             1 (2%)                                
      Subcutaneous Tissue, Epidermis, Hyperplasia,                                                                                  
         Focal                                                                   1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (50)         (50)         (50)                                   
      Hyperostosis                                                  1 (2%)                                                          
   Skeletal Muscle                                    (3)                                    (2)                                    
      Hemorrhage, Focal                                                                       1 (50%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)         (50)                                   
      Compression, Focal                               6 (12%)      8 (16%)     14 (28%)     14 (28%)                               
      Hemorrhage, Focal                                2 (4%)       4 (8%)       1 (2%)       3 (6%)                                
      Hydrocephalus                                                              2 (4%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    7                                                              
                                                                                                                                   
NTP Experiment-Test: 96018-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                        WATER DISINFECTION BYPRODUCTS (BROMODICHLOROMETHANE)                   Date: 05/24/04    
Route: DOSED WATER                                                                                                Time: 09:31:58    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0 MG/L       175 MG/L     350 MG/L     700 MG/L                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
NERVOUS SYSTEM - CONT                                                                                                               
      Necrosis, Focal                                  1 (2%)       2 (4%)                                                          
      Cerebellum, Hemorrhage, Focal                                              1 (2%)                                             
      Cerebrum, Ventricle, Hydrocephalus                            1 (2%)                                                          
      Pineal Gland, Vacuolization Cytoplasmic                                    1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)         (50)         (50)                                   
      Congestion                                       4 (8%)       1 (2%)       3 (6%)       5 (10%)                               
      Fibrosis, Focal                                                                         1 (2%)                                
      Hemorrhage                                       1 (2%)       1 (2%)                    1 (2%)                                
      Hemorrhage, Focal                                3 (6%)       1 (2%)       2 (4%)       2 (4%)                                
      Hyperplasia, Focal, Histiocytic                  1 (2%)       1 (2%)                                                          
      Hyperplasia, Histiocytic                         1 (2%)       1 (2%)                    2 (4%)                                
      Infiltration Cellular, Mixed Cell                2 (4%)                                 1 (2%)                                
      Inflammation, Chronic, Focal                                  2 (4%)       3 (6%)       2 (4%)                                
      Metaplasia, Squamous                                          1 (2%)                                                          
      Alveolar Epithelium, Hyperplasia, Focal          7 (14%)      6 (12%)      9 (18%)      5 (10%)                               
      Interstitium, Edema                              1 (2%)                                                                       
      Mediastinum, Angiectasis, Focal                                                         1 (2%)                                
   Nose                                               (50)         (50)         (50)         (50)                                   
      Hemorrhage                                                    1 (2%)                                                          
      Inflammation, Suppurative                        2 (4%)       3 (6%)       3 (6%)       3 (6%)                                
      Nasolacrimal Duct, Inflammation                                            3 (6%)       1 (2%)                                
      Olfactory Epithelium, Mineralization, Focal                                             1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (49)         (49)         (48)         (47)                                   
      Cataract                                         2 (4%)       1 (2%)       7 (15%)                                            
      Inflammation, Chronic                                                      1 (2%)                                             
      Retina, Degeneration                             3 (6%)       1 (2%)       8 (17%)      1 (2%)                                
   Harderian Gland                                    (50)         (50)         (50)         (48)                                   
      Hyperplasia, Focal, Histiocytic                                            1 (2%)                                             
      Hyperplasia, Focal, Lymphoid                                               1 (2%)                                             
      Hyperplasia, Lymphoid                            1 (2%)                                                                       
      Inflammation, Chronic, Focal                     1 (2%)                    1 (2%)                                             
      Epithelium, Hyperplasia, Focal                                             1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                             Page    8                                                              
                                                                                                                                   
NTP Experiment-Test: 96018-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                        WATER DISINFECTION BYPRODUCTS (BROMODICHLOROMETHANE)                   Date: 05/24/04    
Route: DOSED WATER                                                                                                Time: 09:31:58    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0 MG/L       175 MG/L     350 MG/L     700 MG/L                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (49)         (50)         (50)         (49)                                   
      Cyst                                                                                    1 (2%)                                
      Infarct                                                       3 (6%)       1 (2%)                                             
      Metaplasia, Focal, Osseous                                                 1 (2%)                                             
      Nephropathy                                     49 (100%)    50 (100%)    49 (98%)     46 (94%)                               
      Artery, Thrombosis                                            1 (2%)                                                          
      Cortex, Necrosis, Focal                                                                 1 (2%)                                
      Pelvis, Dilatation                                                         1 (2%)                                             
      Pelvis, Transitional Epithelium, Hyperplasia                                            1 (2%)                                
      Renal Tubule, Hyperplasia, Atypical, Focal                                              1 (2%)                                
      Renal Tubule, Pigmentation                      10 (20%)     13 (26%)      7 (14%)      3 (6%)                                
   Urinary Bladder                                    (49)         (50)         (50)         (49)                                   
      Hemorrhage                                                    1 (2%)       1 (2%)                                             
      Inflammation, Chronic                                                      1 (2%)                                             
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page    9                                                              
                                                                                                                                   
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------